To investigate whether downregulation of GSN could decrease the cytotoxicity of CD8+ T cells in vitro, we isolated primary CAFs and primary ccRCC tumour cells from tumour samples of HLA‐A2+ ccRCC patients, and we also isolated CD8+ T cells from PBMC of the same patient. This evidence concerns the gene CD8A and neoplasm.